Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Fate Therapeutics Inc FATE

Healthcare Biotechnology
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FATE)

FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm

PR Newswire 12 days ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire June 4, 2024

Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference

GlobeNewswire May 29, 2024

Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire May 9, 2024

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program

GlobeNewswire May 9, 2024

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates

GlobeNewswire May 6, 2024

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting

GlobeNewswire May 3, 2024

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

GlobeNewswire April 22, 2024

NOTICE TO LONG-TERM SHAREHOLDERS OF FATE THERAPEUTICS, INC. (FATE): GRABAR LAW OFFICE IS INVESTIGATING CLAIMS ON YOUR BEHALF

Newsfile April 5, 2024
View More News ››

Opinion & Analysis (NDAQ:FATE)

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Streetwise Reports April 7, 2020

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016
View More Opinion ››

Bullboard Posts (NDAQ:FATE)

RE:Article on Finpedia.co

Here's the link:  Fate Therapeutics
wiltonio - January 2, 2019

Article on Finpedia.co

Finpedia is a stock market wiki that is assembling stock background reports for every publicy-traded company in the world. Here is the...
wiltonio - January 2, 2019

Insider buying nov 28

Significant insider buying by director Rastetter William. $999,998 worth of shares on open market but no avg price/share information...
Wepoundem - November 30, 2016

RE:RE:Anyone holding this stock?

It's tough to find good info or insight on this play. I've been in and out for a year now.   Hoping it can hold above $3...
Wepoundem - November 14, 2016

RE:Anyone holding this stock?

Yeah, I've got a few shares. Had a good day on Friday. I mostly follow it on Yahoo but the Yahoo Finance page has been so screwed up...
Pandora - November 12, 2016

Anyone holding this stock?

Is anyone else holding or trading FATE? Its been a decent play for trading on volatility well building a long position. They seem to have...
Wepoundem - November 9, 2016
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. is a Canada-based company, which is engaged in the business of acquiring, exploring and developing ...
View More »